AJANTPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > ajantpharm

Technical Analysis

Technical Strength: 1.62 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 41.6. According to RSI analysis, ajantpharm is technically weak. 1.0 AJANTPHARM RSI Chart
MACD (?) MACD: -8.01 and Signal Line: -3.58. According to MACD analysis, ajantpharm is technically weak. 2.0 AJANTPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, ajantpharm is in a downtrend. Resistance level is at 997. 1.0 AJANTPHARM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, ajantpharm is in a strong downtrend. Major resistance levels are 992.5894, 996.0008, 1014.868. 0.0 AJANTPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.21. According to bollinger bands, ajantpharm is technically weak. 3.0 AJANTPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA AJANTPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 32.6 NA AJANTPHARM Average True Range Chart
Average Directional Index (?) ADX is 21.9 which means AJANTPHARM is in a trading range and there is no trend. NA AJANTPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 19, 2019
Open Price 972.15
High Price 984.0
Low Price 967.0
Close Price 972.15
Absolute Change -0.6
Percentage Change -0.0617%
Weekly Change -1.52%
Monthly Change -3.97%
Yearly Change -8.29%
52-week high 1204.45
52-week low 825.0
Corporate Actions
ExDate Purpose
November 15, 2019 INT DIV-RS 13 PR SH
November 15, 2019 INT DIV
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.704
Confidence in Beta2.25%
Market Capital Rs. 8554.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 November 2019: Deliverable Quantity:9.95e+03 NA AJANTPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 November 2019: Daily Volatility:0.3267 NA AJANTPHARM Annualized Daily Volatility (Spot Price) Chart


July 16, 2018 News Clarification The Exchange has sought clarification from the Company with respect to news item captioned- Ajanta Pharma Drug control In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
April 23, 2018 Trading Window Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 22, 2019 November 05, 2019 Financial Results/Dividend To consider and approve the financial results for the period ended September 30, 2019 and dividend
July 19, 2019 July 31, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play